PATH [to 17 June 2017]
Announcement | June 15, 2017
Administration’s budget devastating for the world’s most vulnerable
New analysis from leading humanitarian, development and global health organizations calculates the devastating human costs of cuts to foreign assistance
[See Reports section below for full text]
Press release | June 12, 2017
United States and Vietnam launch oral HIV pre-exposure option to reduce new infections
Oral HIV pre-exposure prophylaxis (PrEP) is a powerful tool for HIV prevention, especially for those most at risk
UNAIDS [to 17 June 2017]
Selected Press Releases & Updates
Update – 8 June 2017
Partners come together for gender-responsive change management
Partners from across the United Nations system came together on 30 May in UNAIDS headquarters in Geneva, Switzerland, to discuss how behavioural, institutional and cultural change can accelerate progress for gender equality.
In her keynote speech, Jan Beagle, Deputy Executive Director of UNAIDS, emphasized that if change management is undertaken in a gender-responsive manner, barriers to gender equality in the workplace can be addressed and overcome. She shared the progress that UNAIDS has made in gender equality, including near gender parity among staff, 40% of UNAIDS country directors being female and 100% compliance with the performance indicators of the United Nations System-Wide Action Plan on Gender Equality and the Empowerment of Women. She also underlined the need to shift organizational cultures to empower staff everywhere. UNAIDS is taking gender out of isolation and mainstreaming equality and inclusion throughout the Secretariat…
European Medicines Agency [to 17 June 2017]
EMA Management Board: highlights of June 2017 meeting
Focus on Brexit preparations and the development of the EU clinical trial portal and database …
Entry into application of EU Clinical Trial Regulation postponed to 2019
The Board discussed the progress made regarding the development of the EU clinical trial portal and database. Due to technical difficulties with the development of the IT systems, the portal’s go-live date has to be postponed. EMA is working closely with its IT service provider to ensure that corrective measures are implemented and will closely monitor progress. The Board was informed about the mitigation measures taken and the revised plan from the developer. The Agency will provide an update at the next meeting of the Management Board in October 2017 where a new delivery time frame will be discussed once progress with development has been confirmed. Due to these delays, the EU Clinical Trial Regulation will now come into application in 2019 instead of October 2018, as previously scheduled.
EMA’s priority is to ensure that a high quality and functional system is delivered to the EU regulatory network and its stakeholders.
The EU clinical trial portal and database supports the ambitious modernisation of the processes for authorisation and oversight of clinical trials in the EU laid down in the EU Clinical Trial Regulation. The system will provide a single portal for submission and maintenance of clinical trial applications and authorisations, and support coordinated assessment and supervision. The portal and database will also serve as the source of public information on the full lifecycle of all clinical trials conducted in the EU, from their initial review up to the publication of their results.
This is the most ambitious IT system required by the EU legislation in the last decade, involving a complete EU-wide system to be used for clinical trial applications, urgent safety measures and other notifications to regulators before, during and after the conduct of clinical trials.
Wellcome Trust [to 17 June 2017]
News / Published: 17 June 2017
MBE for Beth Thompson in Queen’s Birthday Honours
Beth Thompson, Wellcome’s Head of Policy (UK and EU), has been awarded an MBE for her work on the EU Data Protection Regulation.
Jeremy Farrar, Wellcome’s Director, says: “I am thrilled that Beth Thompson’s outstanding leadership in policy has been recognised today in the Queen’s Birthday Honours. Beth’s determination to bring policy makers, researchers and patients together during negotiations about EU Data Protection Regulation resulted in a solution that allows vital cross-border research to take place while protecting individuals’ privacy.
:: Nearly One in Four New and Expectant Parents Have Never Heard of Invasive Pneumococcal Disease According to a New Survey
Pfizer and Parents Magazine Team Up to Educate Parents About a Serious Disease That Can Put a Child’s Life at Risk
June 13, 2017
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE), in partnership with Parents magazine (NYSE:MDP), announced today the results of a national survey of more than 2,000 new and expectant parents assessing their knowledge of childhood infectious diseases, such as measles, whooping cough and invasive pneumococcal disease (IPD), and the measures parents can take to help prevent them…
Conducted online by Harris Poll, the survey found that parents were least knowledgeable about IPD, when compared among 11 childhood illnesses. In fact, only three of every 10 (30%) parents of children under two years of age and expectant parents report they are knowledgeable about IPD.1 Although IPD may be discussed in well-child visits, nearly one in four (23%) have never even heard of it, illustrating the need for more education.1,2 …